arrow
E

Emanuela Romano

Institut Curie
H指数:34
被引数:6,965

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2− breast cancer: a randomized phase 2 trial

durvalumab和oleclumab新辅助立体定向放射治疗ER HER2 − 乳腺癌: 一项随机2期试验

2026-06-250
OAAI
Correction: CCM-ITALUNG2 pilot on lung cancer screening in Italy: recruitment, integration with smoking cessation and baseline results

更正:意大利肺癌筛查CCM-ITALUNG2试点研究:招募、戒烟整合及基线结果

2025-12-190
PRE
CCM-ITALUNG2 pilot on lung cancer screening in Italy: recruitment, integration with smoking cessation and baseline results

Gorini, G.; Puliti, D.; Picozzi, G.; Giovannoli, J.; Veronesi, G.; Pistelli, F.; Senore, C.; Tessa, C.; Cavigli, E.; Bisanzi, S.; et al. CCM-ITALUNG2试点研究:意大利肺癌筛查、戒烟整合与基线结果。Radiol. Medica 2025. [Google Scholar] [CrossRef]

2025-10-011
PRE
Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial
2025-05-010
PRE
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
RADIOLOGY
IF15.2
2024-09-010
PRE
Association between clinicopathological characteristics and pathological complete response in patients with triple negative breast cancer treated by neoadjuvant chemo-immunotherapy

三阴性乳腺癌患者接受新辅助化疗免疫疗法治疗后,临床病理特征与病理完全缓解之间的关联

2024-09-010
PRE
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

解读乳腺癌中免疫抑制性成纤维细胞的空间景观和可塑性

2024-04-018
OAAI
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
2023-11-025
OAAI
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases
2023-07-135
PRE
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Nivolumab联合放化疗治疗局部晚期宫颈癌: NICOL 1期试验

2023-06-2224
OAAI
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

癌症患者的新型冠状病毒肺炎: 来自esmo-cocare,BSMO和PSMO国际数据库联合分析的更新

2023-06-012
OAAI
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

脂质相关巨噬细胞由癌症相关成纤维细胞诱导并介导乳腺癌的免疫抑制

2022-07-21109
OA
Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome

来自三阴性乳腺癌的细胞外囊泡促进与更好的临床结果相关的促炎性巨噬细胞

2022-04-1962
OAAI
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial
2021-08-0620
OAAI